首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1830966

血管成形術球囊市場

Angioplasty Balloons Market

出版日期: 2025年09月24日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

血管成形術球囊市場預計將從 2024 年的 29 億美元成長到 2031 年的 37.2 億美元，在 2025 年至 2031 年期間實現 3.6% 的複合年成長率。

市場洞察與分析師視角：血管成形術球囊市場的預測為利害關係人制定成長策略提供了寶貴的見解。本報告概述了預測期內的成長機會、市場趨勢及其預期影響。

血管成形術是一種旨在擴張狹窄或阻塞的冠狀動脈以恢復血流的手術。價值導向型醫療的轉變，強調成本效益和病人預後，正在改變醫療保健格局。血管成形術球囊市場將取決於這些設備與其他療法相比，能夠改善患者預後、降低血管重建率並降低成本的能力。與傳統手術方法相比，血管成形術球囊提供了一種治療阻塞動脈的微創方法。由於患者和醫療保健提供者都青睞微創治療方案，對血管成形術球囊的需求正在成長。心血管疾病發生率的上升以及對微創手術的日益青睞，正在推動血管成形術球囊市場的擴張。然而，與血管成形術相關的併發症可能會阻礙市場成長。

成長動力：心血管疾病發病率上升推動血管成形術球囊市場發展世界衛生組織 (WHO) 將心血管疾病確定為全球發病率和死亡率的主要原因。這些疾病包括腦血管疾病、冠狀動脈心臟病和風濕性心臟病。導致心血管疾病的主要生活方式因素包括吸煙、不良飲食和缺乏體能活動。美國心臟協會報告稱，2020 年心血管疾病相關死亡人數從 2019 年的 874,613 人上升至 928,741 人。在美國，冠狀動脈心臟病佔 2020 年心血管疾病死亡人數的 41.2%，其次是中風（17.3%）、高血壓（12.9%）、心臟衰竭（9.2%）、動脈疾病（2.6%）和其他心血管疾病（16.8%）。世界心臟聯盟預計，到 2030 年，每年將有超過 2,300 萬人死於心血管疾病。

此外，心血管危險因子在中歐和西歐普遍存在，這主要是由於吸煙和高酒精消費率，尤其是在男性中。每年有超過400萬歐洲人死於心血管疾病，主要為冠狀動脈疾病和中風。中東地區的心血管疾病發生率也很高，因此需要採取各種干預措施，例如健康教育、生活方式諮詢、篩檢和治療。根據世界心臟聯盟的數據，心血管疾病是中東和北非地區的主要死因，佔所有死亡人數的三分之一以上，每年死亡人數達140萬人。因此，心血管疾病盛行率的上升是血管成形術球囊市場成長的重要驅動力。

雖然血管成形術通常被認為是安全的，但據報道，手術期間或術後可能會出現併發症。風險包括血栓、心律不整、血管或心臟瓣膜損傷、中風、對支架材料或藥物洗脫支架的過敏反應、支架內再狹窄或支架內部阻塞。其中一些風險可能危及生命，並且在某些情況下，例如心臟病發作期間，患者可能沒有足夠的時間接受血管成形術。這些併發症可能會阻礙血管成形術球囊市場的成長。

策略洞察報告細分和範圍：透過檢查以下細分來分析血管成形術球囊市場：類型、應用和最終用戶。

細分分析：依類型分類，血管成形術球囊市場分為普通球囊、藥物洗脫球囊、切割球囊及刻劃球囊。普通球囊在2022年佔據了最大的市場。然而，預計藥物洗脫球囊在2022年至2030年期間的複合年成長率最高。

根據應用，血管成形術球囊市場分為周邊血管成形術球囊和冠狀動脈血管成形術球囊。 2022年，冠狀動脈血管成形術球囊佔據了更大的市場佔有率，預計在2022-2030年期間將呈現最高的複合年成長率，這得益於冠狀動脈疾病（尤其是心臟病）發病率的上升。根據美國疾病管制與預防中心 (CDC) 2023年3月的更新數據，冠心病是最常見的心臟病類型，在20歲及以上的人群中，約有1/20的人患有此病。然而，預計周邊血管成形術球囊在2022-2030年期間將實現更高的複合年成長率。

根據最終用戶，血管成形術球囊市場細分為醫院、門診手術中心和導管室。醫院市場在2022年佔據最大市場佔有率，預計在2022年至2030年期間的複合年成長率最高。

區域分析：血管成形術球囊市場報告的地理範圍涵蓋北美、歐洲、亞太地區、中東和非洲以及南美和中美。 2022年，北美佔據了最大的市場佔有率，其成長動力包括人口老化負擔加重、產品上市數量增加以及持續研發先進血管成形術球囊的努力。

血管成形術球囊市場報告範圍、競爭格局和重點公司：血管成形術球囊市場報告中介紹的重點公司包括雅培、波士頓科學公司、康德樂、庫克醫療、CR Bard Inc、ENDOCOR GmbH、美敦力、Spectranetics、BIOTRONIK 和 Terumo Medical Corporation。這些公司專注於開發新技術、改進現有產品並擴大其地理覆蓋範圍，以滿足日益成長的全球需求。近期的關鍵發展包括：

2023年3月，SIS Medical AG在美國推出了採用TWIN-Wall技術的OPN NC PTCA擴張導管，該導管性能卓越、安全性高，且成功率遠超其他球囊。 OPN NC導管採用TWIN-Wall設計，可提供卓越的耐壓性能，額定爆破壓力高達35個大氣壓力，且順應性顯著降低。 2022年9月，Advanced NanoTherapies公司憑藉其用於治療冠狀動脈疾病的SirPlux Duo藥物塗層球囊(DCB)獲得美國食品藥品監督管理局(FDA)的突破性醫療器材認證(BDD)。 SirPlux Duo DCB能夠低劑量、長期釋放兩種化合物來抑制細胞生長，達到超越任何其他DCB或藥物洗脫支架的最大藥效。 2022年1月，Scoreflex NC Scoring PTCA導管獲得美國食品藥物管理局(FDA)的上市前核准(PMA)。 Scoreflex NC 是一種評分 PTCA 導管，用於治療冠狀動脈缺血患者的冠狀動脈新發狹窄部分和支架內再狹窄，旨在改善心肌灌注。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 12 章：競爭格局

關鍵參與者的熱圖分析
公司定位與集中度

第 13 章：血管成形術球囊市場 - 主要公司簡介

Abbott
Boston Scientific Corporation
Cardinal Health
Cook Medical
BD (C. R. Bard, Inc.)
ENDOCOR GmbH
Medtronic
Spectranetics
BIOTRONIK
Terumo Medical Corporation

第 14 章：附錄

簡介目錄

Product Code: TIPHE100001278

The angioplasty balloons market is expected to increase from US$ 2.90 billion in 2024 to US$ 3.72 billion by 2031, achieving a CAGR of 3.6% during the period from 2025 to 2031.

Market Insights and Analyst Perspective:The forecast for the angioplasty balloons market provides valuable insights for stakeholders to strategize their growth. This report outlines growth opportunities, market trends, and their anticipated effects throughout the forecast period.

Angioplasty is a procedure aimed at widening narrowed or blocked coronary arteries to restore blood flow. The shift towards value-based care, which emphasizes cost-effectiveness and patient outcomes, is transforming the healthcare landscape. The angioplasty balloons market will be shaped by the ability of these devices to enhance patient outcomes, lower revascularization rates, and reduce costs compared to alternative treatments. Angioplasty balloons offer a less invasive approach to treating blocked arteries compared to traditional surgical methods. The demand for angioplasty balloons is increasing as both patients and healthcare providers favor less invasive options. The growing incidence of cardiovascular diseases and the rising preference for minimally invasive procedures are driving the expansion of the angioplasty balloons market. However, complications related to angioplasty may hinder market growth.

Growth Drivers:Rising Incidence of Cardiovascular Diseases Fuels Angioplasty Balloons Market

The World Health Organization (WHO) identifies cardiovascular diseases as the leading cause of morbidity and mortality globally. These diseases encompass cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Key lifestyle factors contributing to cardiovascular diseases include tobacco use, poor diet, and lack of physical activity. The American Heart Association reported that cardiovascular disease-related deaths rose to 928,741 in 2020, up from 874,613 in 2019. In the US, coronary heart disease accounted for 41.2% of cardiovascular disease deaths in 2020, followed by stroke (17.3%), high blood pressure (12.9%), heart failure (9.2%), arterial diseases (2.6%), and other cardiovascular conditions (16.8%). The World Heart Federation anticipates over 23 million deaths annually due to cardiovascular diseases by 2030.

Additionally, cardiovascular risk factors are prevalent in Central and Western Europe, largely due to smoking and high alcohol consumption rates, particularly among men. Over 4 million Europeans die each year from cardiovascular diseases, primarily from coronary artery disease and stroke. The Middle East also experiences a high prevalence of cardiovascular diseases, necessitating various interventions such as health education, lifestyle counseling, screening, and treatment. According to the World Heart Federation, cardiovascular disease is the leading cause of death in the Middle East & North Africa, responsible for over a third of all deaths, totaling 1.4 million annually. Therefore, the increasing prevalence of cardiovascular diseases is a significant driver of growth in the angioplasty balloons market.

While angioplasty procedures are generally considered safe, there are reported complications that can arise during or after the surgery. Risks include blood clots, irregular heartbeats, damage to blood vessels or heart valves, strokes, allergic reactions to stent materials or drug-eluting stents, in-stent restenosis, or blockage of the stent's interior. Some of these risks can be life-threatening, and in certain situations, patients may not have sufficient time to undergo angioplasty, such as during a heart attack. These complications can impede the growth of the angioplasty balloons market.

Strategic Insights

Report Segmentation and Scope:The analysis of the angioplasty balloons market has been conducted by examining the following segments: type, application, and end user.

Segmental Analysis:In terms of type, the angioplasty balloons market is categorized into normal balloons, drug-eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug-eluting balloons segment is projected to exhibit the highest CAGR from 2022 to 2030.

By application, the angioplasty balloons market is divided into peripheral and coronary segments. The coronary segment accounted for a larger share of the angioplasty balloons market in 2022 and is expected to show the highest CAGR during 2022-2030, driven by the rising incidence of coronary artery diseases, particularly heart disease. According to a March 2023 update from the Centers for Disease Control and Prevention (CDC), coronary heart disease is the most common type of heart disease, affecting about 1 in 20 individuals aged 20 and older. Nevertheless, the peripheral segment is anticipated to achieve a higher CAGR during 2022-2030.

Based on end user, the angioplasty balloons market is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest market share in 2022 and is expected to register the highest CAGR from 2022 to 2030.

Regional Analysis:The geographic scope of the angioplasty balloons market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2022, with growth driven by the increasing burden of an aging population, a rising number of product launches, and ongoing R&D efforts to develop advanced angioplasty balloons.

Angioplasty Balloons Market Report Scope

Competitive Landscape and Key Companies:Key companies profiled in the angioplasty balloons market report include Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation. These companies are focused on developing new technologies, enhancing existing products, and expanding their geographic reach to meet the growing global demand. Recent key developments include:

In March 2023, SIS Medical AG launched the OPN NC PTCA Dilatation Catheter with TWIN-Wall technology in the US, offering superior performance and safety with success rates where other balloons fail. The OPN NC catheter features a TWIN-Wall design that provides exceptional pressure resistance with a rated burst pressure of 35 atm and significantly low compliance.

In September 2022, Advanced NanoTherapies received Breakthrough Device Designation (BDD) from the FDA for its SirPlux Duo Drug-Coated Balloon (DCB) aimed at treating coronary artery disease. The SirPlux Duo DCB delivers a low-dose, long-term release of both compounds to inhibit cell growth, achieving maximum potency that surpasses any other DCB or drug-eluting stent.

In January 2022, the Scoreflex NC Scoring PTCA Catheter obtained Premarket Approval (PMA) from the US FDA. The Scoreflex NC is a scoring PTCA catheter indicated for the treatment of de novo stenotic portions of coronary arteries and in-stent restenosis in patients with coronary ischemia, aimed at improving myocardial perfusion.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Angioplasty Balloon Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Angioplasty Balloon Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Angioplasty Balloon Market - Global Market Analysis

6.1 Angioplasty Balloon - Global Market Overview
6.2 Angioplasty Balloon - Global Market and Forecast to 2030

7. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By Type, 2020-2030

7.1 Overview
7.2 Normal Balloons
7.3 Drug Eluting Balloons
7.4 Scoring Balloons
7.5 Cutting Balloon

8. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Coronary
8.3 Peripheral

9. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgery Centers
9.4 Cath Labs

10. Angioplasty Balloon Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Angioplasty Balloon Market Overview
- 10.1.2 North America Angioplasty Balloon Market Revenue and Forecasts to 2030
- 10.1.3 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Type
- 10.1.4 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Material
- 10.1.5 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Application
- 10.1.6 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By End User
- 10.1.7 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.7.1 United States Angioplasty Balloon Market
    - 10.1.7.1.1 United States Angioplasty Balloon Market, by Type
    - 10.1.7.1.2 United States Angioplasty Balloon Market, by Material
    - 10.1.7.1.3 United States Angioplasty Balloon Market, by Application
    - 10.1.7.1.4 United States Angioplasty Balloon Market, by End User
  - 10.1.7.2 Canada Angioplasty Balloon Market
    - 10.1.7.2.1 Canada Angioplasty Balloon Market, by Type
    - 10.1.7.2.2 Canada Angioplasty Balloon Market, by Material
    - 10.1.7.2.3 Canada Angioplasty Balloon Market, by Application
    - 10.1.7.2.4 Canada Angioplasty Balloon Market, by End User
  - 10.1.7.3 Mexico Angioplasty Balloon Market
    - 10.1.7.3.1 Mexico Angioplasty Balloon Market, by Type
    - 10.1.7.3.2 Mexico Angioplasty Balloon Market, by Material
    - 10.1.7.3.3 Mexico Angioplasty Balloon Market, by Application
    - 10.1.7.3.4 Mexico Angioplasty Balloon Market, by End User
10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Angioplasty Balloon Market - Key Company Profiles

13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.3 Cardinal Health
13.4 Cook Medical
13.5 BD (C. R. Bard, Inc.)
13.6 ENDOCOR GmbH
13.7 Medtronic
13.8 Spectranetics
13.9 BIOTRONIK
13.10 Terumo Medical Corporation